首页 | 本学科首页   官方微博 | 高级检索  
检索        

急性呼吸窘迫综合征患者早期应用气道压力释放通气的疗效
引用本文:岳伟岗,向飞,张莹,蒋由飞,袁鹏,冯鑫,尹瑞元,张志刚,李斌.急性呼吸窘迫综合征患者早期应用气道压力释放通气的疗效[J].中华危重症医学杂志(电子版),2020,13(2):93-99.
作者姓名:岳伟岗  向飞  张莹  蒋由飞  袁鹏  冯鑫  尹瑞元  张志刚  李斌
作者单位:1. 730000 兰州,兰州大学第一医院重症监护病房 2. 410013 长沙,中南大学湘雅三医院内科ICU
摘    要:目的探讨早期应用气道压力释放通气(APRV)对急性呼吸窘迫综合征(ARDS)患者的临床疗效。 方法将2017年9月至2019年6月收住在兰州大学第一医院ICU的71例ARDS患者分为APRV组(36例)和小潮气量(LTV)组(35例)。APRV组患者起初给予容量辅助控制通气模式,测量气道平台压后转为APRV模式;LTV组患者接受LTV通气,目标潮气量设置为6~8 mL/kg,依据ARDSnet协议调节呼气末正压(PEEP)水平、潮气量和呼吸频率。记录两组患者的一般资料,比较其机械通气第1天和第7天呼吸机参数、呼吸力学指标、血气功能指标、循环功能指标及预后情况;绘制Kaplan-Meier生存曲线,比较两组患者28 d生存情况。 结果机械通气第7天,APRV组和LTV组患者吸入氧浓度(FiO2)(47 ± 5)% vs.(66 ± 5)%,t = 3.746,P < 0.001]、呼吸频率(24 ± 4)次/min vs.(18 ± 4)次/min,t = 3.453,P < 0.001]、PEEP(5.6 ± 2.3)cmH2O vs.(10.8 ± 4.4)cmH2O,t = 3.011,P < 0.001]、气道峰压23.9(18.5,29.6)cmH2O vs. 25.1(11.3,31.8)cmH2O,H = 2.736,P = 0.014]、气道平台压22.2(18.7,24.3)cmH2O vs. 19.6(17.2,22.4)cmH2O,H = 2.154,P = 0.023]、平均气道压23.8(22.1,24.3)cmH2O vs. 15.4(13.9,19.4)cmH2O,H = 2.814,P = 0.018]、肺顺应性52.7(37.4,62.3)mL/cmH2O vs. 41.8(31.5,57.6)mL/cmH2O,H = 2.008,P = 0.034]、动脉血氧分压(PaO2)(89 ± 7)mmHg vs.(72 ± 7)mmHg,t = 2.324,P < 0.001]、PaO2/FiO2 (201 ± 15)mmHg vs.(140 ± 12)mmHg,t = 2.743,P < 0.001]、动脉血氧饱和度(SaO2)(95.4 ± 2.1)% vs.(92.3 ± 1.8)%,t = 2.658,P < 0.001]、心率(99 ± 9)次/min vs.(108 ± 9)次/min,t = 2.733,P = 0.014]及平均动脉压(84 ± 11)mmHg vs.(74 ± 13)mmHg,t = 3.012,P = 0.011]比较,差异均有统计学意义。APRV组ARDS患者机械通气时间(9.6 ± 2.2)d vs.(11.9 ± 2.9)d,t = 3.687,P < 0.001]、住ICU时间(11.3 ± 3.1)d vs.(13.2 ± 2.7)d,t = 2.722,P = 0.008]、住院时间(13.9 ± 2.5)d vs.(16.2 ± 2.4)d,t = 3.924,P = 0.004]均较LTV组显著缩短,拔管成功率80.6%(29/36)vs. 54.3%(19/35),χ2 = 5.592,P = 0.018]显著升高,肺复张5.6%(2/36)vs. 48.6%(17/35),χ2 = 16.753,P < 0.001]、俯卧位通气11.1%(4/36)vs. 34.3%(12/35),χ2 = 5.460,P = 0.019]、气胸发生率8.3%(3/36)vs. 28.6%(10/35),χ2 = 4.860,P = 0.028]及28 d住院病死率13.9%(5/36)vs. 34.3%(12/35),χ2 = 4.054,P = 0.044]均显著降低。Kaplan-Meier生存曲线结果显示,APRV组ARDS患者生存情况显著优于LTV组(χ2 = 4.118,P = 0.015)。 结论与LTV组比较,早期应用APRV可显著改善ARDS患者的氧合功能和呼吸系统顺应性,提高拔管成功率,降低气胸发生率,并减少机械通气时间和住院时间。

关 键 词:气道压力释放通气  小潮气量  急性呼吸窘迫综合征  
收稿时间:2019-09-20

Clinical efficacy of early application of airway pressure release ventilation on patients with acute respiratory distress syndrome
Weigang Yue,Fei Xiang,Ying Zhang,Youfei Jiang,Peng Yuan,Xin Feng,Ruiyuan Yin,Zhigang Zhang,Bin Li.Clinical efficacy of early application of airway pressure release ventilation on patients with acute respiratory distress syndrome[J].Chinese Journal of Critical Care Medicine ( Electronic Editon),2020,13(2):93-99.
Authors:Weigang Yue  Fei Xiang  Ying Zhang  Youfei Jiang  Peng Yuan  Xin Feng  Ruiyuan Yin  Zhigang Zhang  Bin Li
Institution:1. Department of Intensive Care Medicine, the First Hospital of Lanzhou University, Lanzhou 730000, China 2. Department of Medicine Intensive Care Unit, the Third Xiangya Hospital of Central South University, Changsha 410013, China
Abstract:ObjectiveTo investigate the clinical effect of early application of airway pressure release ventilation (APRV) on patients with acute respiratory distress syndrome (ARDS). MethodsSeventy-one ARDS patients admitted to the Department of Intensive Care Medicine of the First Hospital of Lanzhou University from September 2017 to June 2019 were divided into a APRV group (n = 36) and a low tidal volume (LTV) group (n = 35). Patients in the APRV group were initially given a volume-assisted control ventilation mode and then changed to an APRV mode after measuring airway plateau pressure. At the same time, patients in the LTV group were given LTV ventilation. The target tidal volume was set to 6-8 mL/kg, and the positive end expiratory pressure (PEEP) level, tidal volume and respiratory rate were adjusted according to the ARDSnet protocol in the LTV group. The general data of patients in these two groups were recorded, and the ventilator parameters, respiratory mechanics indexes, blood gas indexes, circulation indexes and prognosis were compared after 1 and 7 days of mechanical ventilation. The Kaplan-Meier survival curves were drawn to compare 28-day survival between these two groups. ResultsAfter 7 days of mechanical ventilation, the fraction of inspiratory oxygen (FiO2) (47 ± 5)% vs. (66 ± 5)%, t = 3.746, P < 0.001], respiratory rate (24 ± 4) breaths/min vs. (18 ± 4) breaths/min, t = 3.453, P < 0.001], PEEP (5.6 ± 2.3) cmH2O vs. (10.8 ± 4.4) cmH2O, t = 3.011, P < 0.001], peak airway pressure 23.9 (18.5, 29.6) cmH2O vs. 25.1 (11.3, 31.8) cmH2O, H = 2.736, P = 0.014], airway platform pressure 22.2 (18.7, 24.3) cmH2O vs. 19.6 (17.2, 22.4) cmH2O, H = 2.154, P = 0.023], mean airway pressure 23.8 (22.1, 24.3) cmH2O vs. 15.4 (13.9, 19.4) cmH2O, H = 2.814, P = 0.018], lung compliance 52.7 (37.4, 62.3) mL/cmH2O vs. 41.8 (31.5, 57.6) mL/cmH2O, H = 2.008, P = 0.034], arterial partial pressure of oxygen (PaO2) (89 ± 7) mmHg vs. (72 ± 7) mmHg, t = 2.324, P < 0.001], PaO2/FiO2 (201 ± 15) mmHg vs. (140 ± 12) mmHg,t = 2.743,P < 0.001], arterial oxygen saturation (SaO2) (95.4 ± 2.1)% vs. (92.3 ± 1.8)%, t = 2.658, P < 0.001], heart rate (99 ± 9) beats/min vs. (108 ± 9) beats/min, t = 2.733, P = 0.014] and mean arterial pressure (84 ± 11) mmHg vs. (74 ± 13) mmHg, t = 3.012, P = 0.011] were statistically significantly different between the APRV group and LTV group. Compared with the LTV group, the mechanical ventilation time (9.6 ± 2.2) d vs. (11.9 ± 2.9) d, t = 3.687, P < 0.001], ICU stay (11.3 ± 3.1) d vs. (13.2 ± 2.7) d, t = 2.722, P = 0.008], and hospital stay (13.9 ± 2.5) d vs. (16.2 ± 2.4) d, t = 3.924, P = 0.004] were significantly shorter, and the successful extubation rate 80.6% (29/36) vs. 54.3% (19/35), χ2 = 5.592, P = 0.018] significantly increased, while the lung recovery 5.6% (2/36) vs. 48.6% (17/35), χ2 = 16.753, P < 0.001], ventilation in prone position 11.1% (4/36) vs. 34.3% (12/35) , χ2 = 5.460, P = 0.019], aerothorax 8.3% (3/36) vs. 28.6% (10/35), χ2 = 4.860, P = 0.028] and 28-day hospitalization mortality 13.9% (5/36) vs. 34.3% (12/35), χ2 = 4.054, P = 0.044] significantly decreased in the APRV group. The Kaplan-Meier survival curve showed that the survival of ARDS patients in the APRV group was significantly better than that in the LTV group (χ2 = 4.118, P = 0.015). ConclusionCompared with the LTV group, early application of APRV can improve oxygenation and respiratory compliance in patients with ARDS, improve their success rate of extubation and reduce their incidence of pneumothorax, duration of mechanical ventilation and length of hospital stay.
Keywords:Airway pressure release ventilation  Low tidal volume  Acute respiratory distress syndrome  
本文献已被 CNKI 等数据库收录!
点击此处可从《中华危重症医学杂志(电子版)》浏览原始摘要信息
点击此处可从《中华危重症医学杂志(电子版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号